Synlett 2021; 32(14): 1433-1436
DOI: 10.1055/a-1534-0343
letter

A Two Hour Synthesis of the Anti-Parkinson Drug Safinamide Methanesulfonate

Vanessa M. Higa
,
Alvaro T. Omori

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brazil (CAPES) (Finance Code 001) and Fundação de Amparo à Pesquisa do Estado de São Paulo - Brazil (FAPESP) (Grant Number 2017/18007-2).


Preview

Abstract

The critical moment of the COVID-19 outbreak requires a real-time supply of therapeutic agents. Thus, time economy in the synthesis of biologically active compounds has become increasingly decisive. In this work, we developed a two hour synthesis of the anti-Parkinson drug safinamide methanesulfonate in four steps with a 64% overall yield. Microwave irradiation was used in the first three steps in a one-pot fashion. In fact, the protocol can provide safinamide free base in one hour without a chromatographic purification step. Also, green solvents such as methanol and ethyl acetate are used.

Supporting Information

Primary Data



Publication History

Received: 19 May 2021

Accepted after revision: 22 June 2021

Accepted Manuscript online:
22 June 2021

Article published online:
09 July 2021

© 2021. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany